Company: STAA
Filing Date: 2025-02-21
Form Type: 10-K
Source: 0000950170-25-024813
Chunk: 5

Company: STAAR SURGICAL CO
Filing Date: 2025-02-21
Form: 10-K
Item: Item 15
Chunk 5
---
We have filed the following documents as part of this Annual Report on Form 10-K:

    Page

    (1)
     
    Consolidated Financial Statements

    Report of Independent Registered Public Accounting Firm
     
    F-2

    Consolidated Balance Sheets
     
    F-4

    Consolidated Statements of Operations
     
    F-5

    Consolidated Statements of Comprehensive Income (Loss)
     
    F-6

    Consolidated Statements of Stockholders’ Equity
     
    F-7

    Consolidated Statements of Cash Flows
     
    F-8

    Notes to Consolidated Financial Statements
     
    F-9

    (2)
     
    Schedules required by Regulation S-X are filed as an exhibit to this report

    II. Schedule II — Valuation and Qualifying Accounts and Reserves
     
    F-40

All other schedules have been omitted because they are not required, not applicable, or the required information is otherwise included.

    (3)

    Index to Exhibits

    Exhibit Number

    Description

    3.1

    Amended and Restated Certificate of Incorporation (incorporated by reference to Appendix 2 of the Company’s Proxy Statement on Form DEF 14A as filed with the Commission on April 26, 2018).

    3.2

    Amended and Restated Bylaws (incorporated by reference to Exhibit 3.1 to the Company’s Current Report on Form 8-K as filed with the Commission on February 1, 2023).

    4.1

    Form of Certificate for Common Stock, par value $0.01 per share (incorporated by reference to Exhibit 4.1 to Amendment No. 1 to the Company’s Registration Statement on Form 8 A/A as filed with the Commission on April 18, 2003).

    4.2

    Description of the Registrant’s Securities (incorporated by reference to Exhibit 4.3 to the Company’s Annual Report on Form 10-K, for the year ended January 3, 2020, as filed with the Commission on February 26, 2020).

    10.1
    #
     
    Form of Indemnity Agreement between the Company and certain officers and directors (incorporated by reference to Exhibit 10.38 to the Company’s Quarterly Report on Form 10-Q, for the period ended June 29, 2018,